vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Terreno Realty Corp (TRNO). Click either name above to swap in a different company.
Terreno Realty Corp is the larger business by last-quarter revenue ($137.5M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, Terreno Realty Corp posted the faster year-over-year revenue change (32.6% vs 27.7%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 27.2%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Terreno Realty Corp is a publicly traded real estate investment trust that specializes in owning, operating, and acquiring high-quality industrial real estate assets. Its portfolio mainly includes distribution warehouses and logistics facilities located in high-demand coastal U.S. metropolitan markets, serving tenants across e-commerce, last-mile delivery, retail supply chain, and light manufacturing segments.
PBYI vs TRNO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $137.5M |
| Net Profit | — | $158.2M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | — |
| Net Margin | — | 115.1% |
| Revenue YoY | 27.7% | 32.6% |
| Net Profit YoY | — | 107.9% |
| EPS (diluted) | $0.26 | $1.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $137.5M | ||
| Q3 25 | $54.5M | $116.2M | ||
| Q2 25 | $52.4M | $112.2M | ||
| Q1 25 | $46.0M | $110.4M | ||
| Q4 24 | $59.1M | $103.7M | ||
| Q3 24 | $80.5M | $99.6M | ||
| Q2 24 | $47.1M | $94.2M | ||
| Q1 24 | $43.8M | $85.0M |
| Q4 25 | — | $158.2M | ||
| Q3 25 | $8.8M | $103.4M | ||
| Q2 25 | $5.9M | $93.3M | ||
| Q1 25 | $3.0M | $48.1M | ||
| Q4 24 | — | $76.1M | ||
| Q3 24 | $20.3M | $36.6M | ||
| Q2 24 | $-4.5M | $35.7M | ||
| Q1 24 | $-4.8M | $36.1M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | — | 115.1% | ||
| Q3 25 | 16.2% | 88.9% | ||
| Q2 25 | 11.2% | 83.1% | ||
| Q1 25 | 6.5% | 43.6% | ||
| Q4 24 | — | 73.4% | ||
| Q3 24 | 25.2% | 36.8% | ||
| Q2 24 | -9.6% | 37.9% | ||
| Q1 24 | -11.0% | 42.4% |
| Q4 25 | $0.26 | $1.54 | ||
| Q3 25 | $0.17 | $1.00 | ||
| Q2 25 | $0.12 | $0.90 | ||
| Q1 25 | $0.06 | $0.47 | ||
| Q4 24 | $0.40 | $0.78 | ||
| Q3 24 | $0.41 | $0.37 | ||
| Q2 24 | $-0.09 | $0.37 | ||
| Q1 24 | $-0.10 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $25.0M |
| Total DebtLower is stronger | $22.7M | $943.3M |
| Stockholders' EquityBook value | $130.3M | $4.1B |
| Total Assets | $216.3M | $5.4B |
| Debt / EquityLower = less leverage | 0.17× | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $25.0M | ||
| Q3 25 | $94.4M | $26.2M | ||
| Q2 25 | $96.0M | $128.4M | ||
| Q1 25 | $93.2M | $156.5M | ||
| Q4 24 | $101.0M | $18.1M | ||
| Q3 24 | $96.7M | $243.7M | ||
| Q2 24 | $96.8M | $182.0M | ||
| Q1 24 | $107.2M | $649.6M |
| Q4 25 | $22.7M | $943.3M | ||
| Q3 25 | $34.0M | $1.0B | ||
| Q2 25 | $45.3M | $742.4M | ||
| Q1 25 | $56.7M | $741.9M | ||
| Q4 24 | $68.0M | $823.4M | ||
| Q3 24 | $79.3M | $672.2M | ||
| Q2 24 | $90.7M | $772.0M | ||
| Q1 24 | $102.0M | $771.8M |
| Q4 25 | $130.3M | $4.1B | ||
| Q3 25 | $115.3M | $4.0B | ||
| Q2 25 | $104.7M | $3.9B | ||
| Q1 25 | $97.1M | $3.9B | ||
| Q4 24 | $92.1M | $3.7B | ||
| Q3 24 | $71.1M | $3.6B | ||
| Q2 24 | $48.5M | $3.4B | ||
| Q1 24 | $51.0M | $3.4B |
| Q4 25 | $216.3M | $5.4B | ||
| Q3 25 | $202.9M | $5.3B | ||
| Q2 25 | $194.9M | $5.0B | ||
| Q1 25 | $196.2M | $4.9B | ||
| Q4 24 | $213.3M | $4.8B | ||
| Q3 24 | $220.7M | $4.6B | ||
| Q2 24 | $205.0M | $4.5B | ||
| Q1 24 | $214.1M | $4.4B |
| Q4 25 | 0.17× | 0.23× | ||
| Q3 25 | 0.30× | 0.26× | ||
| Q2 25 | 0.43× | 0.19× | ||
| Q1 25 | 0.58× | 0.19× | ||
| Q4 24 | 0.74× | 0.22× | ||
| Q3 24 | 1.12× | 0.19× | ||
| Q2 24 | 1.87× | 0.22× | ||
| Q1 24 | 2.00× | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $271.9M |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $271.9M | ||
| Q3 25 | $9.7M | $79.5M | ||
| Q2 25 | $14.1M | $60.6M | ||
| Q1 25 | $3.6M | $61.4M | ||
| Q4 24 | $15.6M | $232.7M | ||
| Q3 24 | $11.0M | $70.0M | ||
| Q2 24 | $1.0M | $64.3M | ||
| Q1 24 | $11.2M | $47.0M |
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | 1.72× | ||
| Q3 25 | 1.10× | 0.77× | ||
| Q2 25 | 2.41× | 0.65× | ||
| Q1 25 | 1.21× | 1.28× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | 0.54× | 1.91× | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | — | 1.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
TRNO
| Disposal Group Disposed Of By Sale Not Discontinued Operations | $109.5M | 80% |
| Other | $23.8M | 17% |
| At Market Equity Offering Program500Million | $4.1M | 3% |
